News
INX-315 is an oral, investigational selective cyclin-dependent kinase 2 (CDK2) inhibitor. The designation was based on preclinical data as well as interim data from the ongoing phase 1/2 INX-315-01 ...
Bank AlJazira’s Q1 2025 profit jumps 20% to SAR 361M 3 M 2025 Bank AlJazira profit up 21% to SAR 1.23B in 2024; Q4 at SAR 280.3M 12 M 2024 Bank AlJazira profit grows to SAR 950.7M in 9M 2024; Q3 at ...
Real time quote data is not available at this time. *Data is provided by Barchart.com. Data reflects weightings calculated at the beginning of each month. Data is subject to change. **Green ...
Real time quote data is not available at this time. *Data is provided by Barchart.com. Data reflects weightings calculated at the beginning of each month. Data is subject to change. **Green ...
S&P 500 Has Best Day Since 2008 as Trump Pauses Tariffs ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results